Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpire Healthcare Regulatory News (SPI)

Share Price Information for Spire Healthcare (SPI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 250.00
Bid: 247.50
Ask: 248.00
Change: 3.50 (1.42%)
Spread: 0.50 (0.202%)
Open: 247.00
High: 250.00
Low: 247.00
Prev. Close: 246.50
SPI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI)

14 Jul 2021 10:58

RNS Number : 2305F
GoldmanSachs International
14 July 2021
 

 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

(GS) GOLDMAN SACHS INTERNATIONAL

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

SPIRE HEALTHCARE GROUP PLC

(c) Name of the party to the offer with which exempt principal trader is connected:

SPIRE HEALTHCARE GROUP PLC

(d) Date dealing undertaken:

13 July 2021

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

1p ordinary

Purchases

159,512

2.3500 GBP

2.2800 GBP

1p ordinary

Sales

687,246

2.3500 GBP

2.2850 GBP

 

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

1p ordinary

CFD

Increasing a short position

1,578

2.2802 GBP

1p ordinary

CFD

Reducing a short position

75,325

2.2947 GBP

1p ordinary

CFD

Increasing a short position

1,399

2.3052 GBP

1p ordinary

CFD

Increasing a short position

5,604

2.3145 GBP

1p ordinary

CFD

Reducing a short position

36,718

2.3160 GBP

1p ordinary

CFD

Reducing a short position

8,985

2.3160 GBP

1p ordinary

CFD

Reducing a short position

8,989

2.3160 GBP

1p ordinary

CFD

Reducing a short position

31,816

2.3160 GBP

1p ordinary

CFD

Reducing a short position

105,582

2.3160 GBP

1p ordinary

CFD

Reducing a short position

6,440

2.3160 GBP

1p ordinary

CFD

Reducing a short position

215,883

2.3160 GBP

1p ordinary

CFD

Reducing a short position

85,587

2.3160 GBP

1p ordinary

CFD

Reducing a short position

98,693

2.3229 GBP

1p ordinary

CFD

Increasing a short position

147,019

2.3261 GBP

1p ordinary

CFD

Reducing a short position

8,134

2.3497 GBP

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising / exercised against

Number of securities

Exercise price per unit

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

 

Date of disclosure:

14 July 2021

Contact name:

Paul Grainger and Kashif Rafiq

Telephone number:

+44(20) 7552 9835 / +44(20) 7051 0547

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERGCGDRRUBDGBS
Date   Source Headline
22nd Apr 20247:00 amRNSMajor Contract Win with Spire Healthcare
17th Apr 20247:00 amRNSCapital Markets Event
4th Apr 202411:13 amRNSNotice of AGM
4th Apr 202410:35 amRNSBlock listing Interim Review
3rd Apr 20247:00 amRNSPortfolio management: Spire Tunbridge Wells
2nd Apr 20243:42 pmRNSTotal Voting Rights
28th Mar 20241:54 pmRNSDirector/PDMR Shareholding
21st Mar 20247:00 amRNSNotice of Capital Markets Event
15th Mar 202410:07 amRNSDirector/PDMR Shareholding
1st Mar 20244:35 pmRNSTotal Voting Rights
29th Feb 20247:00 amRNSCFO transition
29th Feb 20247:00 amRNSFinal Results
13th Feb 20247:31 amRNSHolding(s) in Company
1st Feb 20247:00 amRNSTotal Voting Rights and Capital
29th Jan 20247:00 amRNSNotice of Preliminary Results
11th Jan 20243:18 pmRNSBlock listing Interim Review
1st Dec 20237:00 amRNSTotal Voting Rights and Capital
1st Nov 20239:47 amRNSTotal Voting Rights
20th Oct 202311:21 amRNSDirector/PDMR Shareholding
19th Oct 20237:00 amRNSAcquisition of Vita Health Group
2nd Oct 20232:57 pmRNSTotal Voting Rights
2nd Oct 20239:19 amRNSBlock listing Interim Review
14th Sep 20237:00 amRNSHalf-year Report
1st Sep 20233:52 pmRNSTotal Voting Rights
11th Aug 20238:15 amRNSHolding(s) in Company
10th Aug 20237:00 amRNSNotice of Interim Results
1st Aug 20239:04 amRNSTotal Voting Rights
13th Jul 20233:15 pmRNSDirector Declaration
11th Jul 20237:49 amRNSBlock listing Interim Review
1st Jun 20239:12 amRNSTotal Voting Rights
11th May 20232:20 pmRNSResults of 2023 Annual General Meeting
11th May 20237:00 amRNSAGM Statement
12th Apr 20234:22 pmRNSDirector/PDMR Shareholding
3rd Apr 202312:04 pmRNSAnnual Financial Report
3rd Apr 20238:07 amRNSTotal Voting Rights
30th Mar 20233:18 pmRNSBlock listing Interim Review
30th Mar 20232:48 pmRNSDirector/PDMR Shareholding
16th Mar 202310:00 amRNSDirector/PDMR Shareholding
9th Mar 20239:18 amRNSDirector/PDMR Shareholding
2nd Mar 20237:00 amRNSFinal Results
28th Feb 20234:01 pmRNSDirector Declaration
9th Feb 20237:00 amRNSPreliminary Results Presentation – Change of Venue
1st Feb 202310:52 amRNSTotal Voting Rights
23rd Jan 20237:00 amRNSNotice of Preliminary Results
20th Jan 20239:30 amRNSDirector Declaration
12th Jan 20239:42 amRNSBlock listing Interim Review
3rd Jan 20232:00 pmRNSTotal Voting Rights
19th Dec 20227:00 amRNSAcquisition of The Doctors Clinic Group Limited
1st Dec 202210:02 amRNSTotal Voting Rights
1st Nov 20221:24 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.